Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 10—October 2005

Vancomycin and Home Health Care

Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*Comments to Author 
Author affiliations: *Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; †University of Illinois at Chicago School of Public Health, Chicago, Illinois, USA; ‡Northwestern Memorial Hospital, Chicago, Illinois, USA

Main Article

Table 2

Comparison of HICPAC guidelines with home infusion use of vancomycin in 296 patients*

No. (%)
Manner in which vancomycin use met guidelines 180 (60.8)
Treatment of infections with β-lactam-resistant, gram-positive bacteria 118 (65.6)
Treatment of gram-positive infections in patients with allergies to β-lactam agents 67 (37.2)
Manner in which vancomycin use did not meet guidelines 116 (39.2)
Continued empiric vancomycin use in patients with negative or no cultures 84 (72.4)
Use of vancomycin for dosing convenience 18 (15.5)
Prolonged administration of antimicrobial drugs after implantation of prosthetic materials or devices 13 (11.2)
Treatment of a single blood culture showing coagulase-negative staphylococci 9 (7.8)

*Some patients fulfilled >1 criteria. HICPAC, Hospital Infection Control Practices Advisory Committee.

Main Article

1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA

Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.